Tue, Sep 16, 2014, 8:55 AM EDT - U.S. Markets open in 35 mins.


% | $
Quotes you view appear here for quick access.

Exelixis, Inc. Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • fredsteinberg70 fredsteinberg70 Mar 31, 2012 8:29 PM Flag

    Doubling of Outstanding Shares

    Wilder, understandly, many Companies have asked shareholders for increasing their number of shares citing the same thing as preventing a hostile takeover. I am all for exel to be a winner. I have suspiscious reservations regarding any Company who have issued shares 2 times in a year and being far off from FDA approvals while many trials are pending . Priority lies with going it alone, for EXEL, thus diluting shares for future trials. Remember EXEL was a darling when it had revenues coming it, it helped offset cost of trials. Today priority lies with exel cash balance to complete their trials . At this rate of Issuance of shares, exel may have over 200M -300M OS before even being considered for FDA acceptance for approvals. Many more times of diluting if EXEL doesn't get a partnership going. PPS will suffer, unless Insiders hold all those new Issuance. Good luck, will be watching, short interest are not making it any better.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • $$$$

      Thanks for the input, Fred. I'm gathering advice where I can find it, and I appreciate your efforts.

      The short interest has been a pain - of course - but further dilution could prove too much to care to witness. I'm sure this vote will be carefully watched, as will be the near-term burn rate between now & the annual meeting.

1.74-0.13(-6.95%)Sep 15 4:00 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.